Combination treatment with Tecvayli (teclistamab-cqyv) and Darzalex Faspro (daratumumab and hyaluronidase-fihj) led to a 100% response rate for 49 people with newly diagnosed…
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Combination treatment with Tecvayli (teclistamab-cqyv) and Darzalex Faspro (daratumumab and hyaluronidase-fihj) led to a 100% response rate for 49 people with newly diagnosed…
Discussion
When my mum, Esther, was diagnosed with myeloma in January 2021, our world split in two. There was the life we thought we were…
Discussion
I recently went to the supermarket to pick up some groceries. While I was shopping for avocados, an acquaintance approached me. “How is your mother?”…
Over a 15-year period, the median survival time for people with myeloma has nearly doubled, increasing from 2.4 years for those diagnosed in 2005…
Discussion
It started like any ordinary ache — something my mum, Esther, was all too familiar with. She often woke up with a crick in her…
Discussion
The first time I saw a patient all by himself in the infusion room, I didn’t notice him. No, that’s not what happened. On that…
Don't have an account?
|
Already have an account?
Create your account by filling in the information below:
By creating an account, you are agreeing to the Privacy Policy and Terms of Service.